We are live on ! Find out more
EIP

Epoch Investment Partners Portfolio holdings

AUM $16.5B
1-Year Est. Return 24.3%
This Fund
S&P 500
This Quarter Est. Return
+10.92%
1 Year Est. Return
+24.3%
3 Year Est. Return
+77.95%
5 Year Est. Return
+103.29%
10 Year Est. Return
+404.8%
AUM
$22.5B
AUM Growth
+$531M
Cap. Flow
-$1.53B
Cap. Flow %
-6.78%
Top 10 Hldgs %
16.04%
Holding
434
New
23
Increased
133
Reduced
230
Closed
26

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$305M
2
MSFT icon
Microsoft
MSFT
+$269M
3
NVDA icon
NVIDIA
NVDA
+$191M
4
LLY icon
Eli Lilly
LLY
+$184M
5
AMZN icon
Amazon
AMZN
+$139M

Sector Composition

Rank Sector Weight
1 Technology 22.37%
2 Healthcare 17.03%
3 Financials 13.96%
4 Industrials 11.52%
5 Consumer Discretionary 10.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLF icon
326
Cleveland-Cliffs
CLF
$7.07B
$1.06M ﹤0.01%
46,568
-33,713
-42% -$668K
GNRC icon
327
Generac Holdings
GNRC
$12.6B
$1.05M ﹤0.01%
+8,346
New +$979K
MCO icon
328
Moody's
MCO
$82.6B
$1.05M ﹤0.01%
2,673
BEPC icon
329
Brookfield Renewable
BEPC
$6.46B
$1.04M ﹤0.01%
42,267
-2,041,597
-98% -$53.5M
VNT icon
330
Vontier
VNT
$4.64B
$1.03M ﹤0.01%
22,647
-280,028
-93% -$10.9M
CHKP icon
331
Check Point Software Technologies
CHKP
$13.2B
$998K ﹤0.01%
6,086
PSX icon
332
Phillips 66
PSX
$89.4B
$997K ﹤0.01%
6,102
-87
-1% -$12.5K
CAT icon
333
Caterpillar
CAT
$388B
$984K ﹤0.01%
2,686
-113
-4% -$36.1K
XRAY icon
334
Dentsply Sirona
XRAY
$2.34B
$980K ﹤0.01%
29,522
-1,950
-6% -$66.6K
CALF icon
335
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.86B
$964K ﹤0.01%
19,600
GS icon
336
Goldman Sachs
GS
$301B
$919K ﹤0.01%
2,199
-43
-2% -$16.7K
CLX icon
337
Clorox
CLX
$13.1B
$900K ﹤0.01%
5,877
-52
-0.9% -$7.76K
BLKB icon
338
Blackbaud
BLKB
$2.06B
$884K ﹤0.01%
+11,917
New +$910K
KHC icon
339
Kraft Heinz
KHC
$29.2B
$879K ﹤0.01%
23,822
-1,608,427
-99% -$58.4M
SWK icon
340
Stanley Black & Decker
SWK
$15.7B
$874K ﹤0.01%
8,926
KKR icon
341
KKR & Co
KKR
$99.4B
$870K ﹤0.01%
8,646
-1,127
-12% -$104K
CHD icon
342
Church & Dwight Co
CHD
$24.4B
$863K ﹤0.01%
8,278
MPC icon
343
Marathon Petroleum
MPC
$93.7B
$836K ﹤0.01%
4,149
-68
-2% -$11.6K
NVS icon
344
Novartis
NVS
$295B
$816K ﹤0.01%
8,436
-24
-0.3% -$2.46K
DG icon
345
Dollar General
DG
$26.5B
$801K ﹤0.01%
5,135
-122
-2% -$17.3K
CI icon
346
Cigna
CI
$71.9B
$773K ﹤0.01%
2,127
-563
-21% -$185K
IFF icon
347
International Flavors & Fragrances
IFF
$21.7B
$771K ﹤0.01%
8,967
-75
-0.8% -$6.02K
XPO icon
348
XPO
XPO
$23.9B
$770K ﹤0.01%
6,312
-821
-12% -$87.9K
AFL icon
349
Aflac
AFL
$61B
$732K ﹤0.01%
8,530
-1,651
-16% -$135K
MU icon
350
Micron Technology
MU
$974B
$730K ﹤0.01%
6,188
-861
-12% -$77.9K

Similar funds

Epoch Investment Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Epoch Investment Partners held 434 positions worth $22.5B, up 2.4% from $22B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Epoch Investment Partners withdrew a net $1.53B in Q1 2024, closing 26 positions and reducing 230 holdings. Its most notable exit was Berry Global Group, Inc., an estimated $69.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Epoch Investment Partners opened a new position in Regeneron Pharmaceuticals worth $99.7M.

  • Epoch Investment Partners's largest Q1 2024 buy was Regeneron Pharmaceuticals: 103,551 shares worth $99.7M.
  • Epoch Investment Partners added most to Zoetis in Q1 2024, an estimated $60.9M increase.
  • Epoch Investment Partners's biggest Q1 2024 reduction was Apple, cutting an estimated $305M.
  • Epoch Investment Partners fully exited Berry Global Group, Inc. in Q1 2024, selling an estimated $69.7M.
  • Epoch Investment Partners's ten largest holdings make up 16% of its $22.5B portfolio in Q1 2024.
  • Epoch Investment Partners opened 23 new positions and closed 26 in Q1 2024.
  • Epoch Investment Partners's portfolio value rose 2.4% quarter-over-quarter to $22.5B.

Based on Epoch Investment Partners's 13F filing for Q1 2024, filed 14 May 2024.